Vacancy has expired
Show me jobs like this one| Job Ref: | BV27011 |
| Job Type: | Full Time |
| State: | Ohio (OH) |
| City: | Bedford |
| Post Code: | Sep 30, 2011 |
| Job Description: |
Boehringer Ingelheim is now hiring an Pharmaceutical Technician, Sterile Filling for our Bedford, OH location. JOB DESCRIPTION: Ben Venue Laboratories (BVL) is currently seeking a talented and innovative Scientist IV to join our Product and Process Development (PPD) department located at our Bedford, OH site. The Scientist IV demonstrates a solid level of technical proficiency in field. As a team member you will be responsible for developing small volume parenteral products from pre-formulation through transfer to manufacturing. You may be involved in training and mentoring junior level scientific staff. As an employee, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees. DUTIES AND RESPONSIBILITIES: Initiates, designs, accurately interprets, troubleshoots and completes routine and non-routine procedures independently and efficiently Develop parenteral products from preformulation through transfer to manufacturing, including solubility, pH, dissolution, and others attributes related to effects on stability, delivery, applicability to lyophilization, and container/closure selection, in collaboration with other PPD scientific staff. Play a significant role in the technology transfer process in collaboration with Pilot Plant and Production personnel Be involved in the development and evaluation of proposed formulations, processing procedures and selected container/closure systems through pilot batch testing and development stability studies. Be responsible for analytical method development and any required validation activities, support for formulation development including stability studies, sourcing of new drug substances, and implementation of new technology. Be involved in the evaluation of formulation and components on/for stability, tonicity, viscosity, antioxidant/preservative compatibility, as well as any other critical attributes. Prepare protocols and reports to support the justification, results and impact of analytical method development, formulation development, process development, and other studies performed in the position. Independently applies basic scientific principles, technology and regulatory knowledge. Performs literature searches, attends scientific meetings, and keeps abreast of literature in own field Propose new experimental designs, conduct probing experiments. Plan and conduct laboratory experiments and evaluate and interpret data. Prepare technical reports, publications and oral presentations Provide training and guidance to laboratory personnel Effectively communicates and defends own work, orally and in writing, in the context of the team goals at meetings and with external vendors and customers Participate in cross departmental project teams when assigned Generate documents in support of Regulatory submissions and may author portions of CMC for submissions Be responsible for the development, implementation and analysis of results using advanced instrumental and wet chemistry procedures. Proposes, gains support for and implements ideas from individual's knowledge of the drug development process Accept responsibility and provide leadership for the execution and completion of assigned projects Independently manage work activities and adherence to agreed upon timelines Requirements QUALIFICATIONS: |
| Post Date: | 10/01/2011 |
